TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Chemotechnique Mb Diagnostics AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
6,168
|
5,125
|
5,091 |
| Financial expenses |
1
|
0
|
1 |
| Earnings before taxes |
1,735
|
1,374
|
1,190 |
| EBITDA |
1,800
|
1,495
|
1,349 |
| Total assets |
5,317
|
4,607
|
4,342 |
| Current assets |
5,042
|
4,239
|
3,868 |
| Current liabilities |
1,554
|
1,437
|
1,279 |
| Equity capital |
3,732
|
3,088
|
2,924 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
35
|
32
|
30 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
70.2%
|
67.0%
|
67.3% |
| Turnover per employee |
176
|
160
|
170 |
| Profit as a percentage of turnover |
28.1%
|
26.8%
|
23.4% |
| Return on assets (ROA) |
32.6%
|
29.8%
|
27.4% |
| Current ratio |
324.5%
|
295.0%
|
302.4% |
| Return on equity (ROE) |
46.5%
|
44.5%
|
40.7% |
| Change turnover |
1,028
|
446
|
973 |
| Change turnover % |
20%
|
10%
|
24% |
| Chg. No. of employees |
3
|
2
|
2 |
| Chg. No. of employees % |
9%
|
7%
|
7% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.